Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutation.
Galimberti
C A
CA
Epilepsy Centre, I.R.C.C.S. Institute of Neurology C. Mondino Foundation, Pavia, Italy. carloandrea.galimberti@mondino.it
Diegoli
M
M
Sartori
I
I
Uggetti
C
C
Brega
A
A
Tartara
A
A
Arbustini
E
E
D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects; D001284:Atrophy / Q000139:chemically induced* / Q000235:genetics / Q000473:pathology; D001921:Brain / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D002648:Child; D003072:Cognition Disorders / Q000139:chemically induced* / Q000235:genetics / Q000503:physiopathology; D004252:DNA Mutational Analysis; D004272:DNA, Mitochondrial / Q000235:genetics*; D002658:Developmental Disabilities / Q000139:chemically induced* / Q000235:genetics / Q000503:physiopathology; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007360:Intelligence / Q000187:drug effects / Q000235:genetics; D007361:Intelligence Tests; D008279:Magnetic Resonance Imaging; D008297:Male; D009154:Mutation / Q000235:genetics; D011110:Polymorphism, Genetic / Q000235:genetics; D014635:Valproic Acid / Q000009:adverse effects*
D000927:Anticonvulsants; D004272:DNA, Mitochondrial; D014635:Valproic Acid